Taking steps to ensure equitable access for specific populations will not significantly reduce financial incentives for pharma companies to continue developing better versions of these treatments
[2] Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M
The company has become the first Indian pharmaceutical firm to receive approval from the Drugs Controller General of India (DCGI) for a generic version of semaglutide
Aurora is Colorado's most diverse city, with over a third of residents speaking a language other than English at home
One commenter questioned our analysis that only 10 percent of hospitals nationwide would report multiple NPIs
Helps fade dark areas and spots